Novo Nordisk

Plainsboro, United States Founded: 1923 • Age: 103 yrs
Novo Nordisk is focused on developing pharmaceutical treatments.

About Novo Nordisk

Novo Nordisk is a Healthcare company based in Plainsboro (United States) founded in 1923. Novo Nordisk is focused on developing pharmaceutical treatments. It operates on a HealthTech model. The company has 2 employees. Its website novonordisk-us.com draws about 89 thousand monthly visits. Novo Nordisk offers products and services including Awiqli, Mim8, and Wegovy. Its focus areas include Pharmaceuticals and Biotechnology. Its legal entity is Novo Nordisk A/S. Its competitors include iMedX, Centivo and Omega Healthcare; 2 of its 3 listed competitors have raised funding.

Company details

Novo Nordisk is engaged in the development and provision of pharmaceutical solutions primarily targeting diabetes, obesity, hemophilia, and growth hormone disorders. The company is recognized for innovative treatments such as Awiqli, a potential once-weekly basal insulin for type 2 diabetes, Mim8 for hemophilia A prophylaxis, and Wegovy for obesity management. Operations are centered in the healthcare sector with a commitment to sustainable business practices and partnerships for innovation.

  • Headquarters Plainsboro, United States
  • Employees 2
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Phone
    •••• ••••
  • Website novonordisk-us.com
  • Social X Facebook Instagram
  • Legal Name Novo Nordisk A/S
Key Metrics
  • Employee Count
    2

Products & Services of Novo Nordisk

Novo Nordisk offers a comprehensive portfolio of products and services, including Awiqli, Mim8, and Wegovy.

Awiqli
Pharmaceuticals

Awiqli is developed as once-weekly basal insulin treatment.

Mim8
Pharmaceuticals

Mim8 is investigated for hemophilia A prophylaxis treatment.

Wegovy
Pharmaceuticals

Wegovy is formulated for obesity weight loss treatment.

People of Novo Nordisk

1136 people are tracked at Novo Nordisk (545 in leadership, 9 in board & advisors, 582 in team); the tracked headcount is 2.

NameRoleGroup
Anne-Kristine Prag Steinitz
Corporate Vice President Strategic Scientific Communication, Global Medical AffairsLeadership
Cecilie Heerdegen Jepsen
Head Of Translational MedicineLeadership
Malgorzata Wnuk
Strategic Finance & Project DirectorLeadership
Allegra Kaufman
Executive Director, Clinical Development StrategyLeadership
Greg Horikoshi
Associate Director Commercial ExecutionLeadership
Claudia Laven
Vice President | Obesity CareLeadership
David Scott
Director, Legal, Ethics, Compliance And QualityLeadership
Sofie Inari Castella
Global Director, Scientific PublicationsLeadership
Rasmus Sonne Henniker Heaton
Sr. Business & Project PartnerLeadership
Ghita Bahbouhi
Supply Chain Analytics PartnerLeadership
Teresa Sophie K.
Director, IME & Medical Association PartnershipsLeadership
Ulrik Ullum
Senior DirectorLeadership
Katy Long
Snr Dir, HR Business Partner, International OperationsLeadership
Victor Vazquez
Talent Acquisition Partner Americas (latam, USA & Canada)Leadership
Al Willis
Senior Director - Deployment Strategy & Sales InnovationLeadership
Morten Engelund
Corporate Vice President, Total Rewards And MobilityLeadership
Briana Dunn
Associate Director Search And EvaluationLeadership
Jacob Sten Petersen
Corporate Vice President, Stem Cell R&DLeadership
Konstantinos Ratsikas
Senior Supply Chain PartnerLeadership
Pratik Dherange
Associate Director, Regulatory Affairs StrategyLeadership

1116 more people are available in the full profile.

Premium access

Complete people profiles for Novo Nordisk

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Competitors of Novo Nordisk

Novo Nordisk has 3 listed competitors in our database, 2 of them funded. They include iMedX, Centivo and Omega Healthcare.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
imedx.com2002Atlanta, United States$22.28M951
Revenue cycle management platform is provided to healthcare providers.
centivo.com2017New York, United States$224M212
Provider of self funded health plan
omegahms.com2003Boca Raton, United States26,750
Healthcare outsourcing services are provided to various sectors.
Premium access

Detailed competitors of Novo Nordisk

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Novo Nordisk

The website of Novo Nordisk (novonordisk-us.com) receives about 89K visits a month and ranks #469,241 among all websites worldwide, #447 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    89K

    ▲ 13.2% vs previous month

  • Unique visitors
    45.4K

    per month

  • Global rank
    #469,241

    among all websites

  • Category rank
    #447

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Novo Nordisk. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
novonordisk.com
96%
637.8K#83,485View details
catalent.com
83%
116.7K#338,870View details
daiichisankyo.com
83%
72.3K#682,883View details
sterlingpharmasolutions.com
78%
12.2K#2,060,032View details
eisai.com
77%
74.5K#534,857View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 10 similar websites and full traffic analytics for Novo Nordisk

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 10 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Healthcare Provider Support Services

3 companies that operate in the same segment as Novo Nordisk (Healthcare Provider Support Services) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of self funded health plan
2017New York, New York, United StatesUSD 224 M212
Provider of AI solutions for clinical, operational, and business outcomes
2005Princeton, New Jersey, United StatesUSD 1.13 BUSD 465.22 M5,442
AMN Healthcare is recognized as a leading healthcare staffing provider.
1985San Diego, California, United StatesUSD 2.73 B2,970
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Novo Nordisk

Premium access

Complete news archive for Novo Nordisk

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Novo Nordisk

Novo Nordisk was founded in 1923.

Novo Nordisk is headquartered in Plainsboro, United States. It is registered at Plainsboro, New Jersey, United States.

Novo Nordisk has 2 employees.

Novo Nordisk is engaged in the development and provision of pharmaceutical solutions primarily targeting diabetes, obesity, hemophilia, and growth hormone disorders. The company is recognized for innovative treatments such as Awiqli, a potential once-weekly basal insulin for type 2 diabetes, Mim8 for hemophilia A prophylaxis, and Wegovy for obesity management. Operations are centered in the healthcare sector with a commitment to sustainable business practices and partnerships for innovation.

Novo Nordisk's top competitors include Centivo, Omega Healthcare and iMedX.

Novo Nordisk offers Awiqli, Mim8, and Wegovy.

Novo Nordisk operates through Novo Nordisk A/S.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available